Pricey Precision Medicine Often Financially Toxic For Cancer Patients | Latest News RSS feed

Pricey Precision Medicine Often Financially Toxic For Cancer Patients - Latest News


Pricey Precision Medicine Often Financially Toxic For Cancer Patients

When Kristen Kilmer was diagnosed with incurable breast cancer at age 38, her first thought was of her 8-year-old daughter. Kilmer lost her own mother as a teenager and was determined to get more time ... read more

NCCN Patient Advocacy Summit Examines Disparities in Cancer Care and Explores Solutions

Potential solutions, including treatment online or by phone, often ... the financial toxicity concerns from the treatment itself, according to the panelists. "Socioeconomic factors play a major role i... read more

For Some Patients Financial Toxicity Is Real And Getting Worse

While from a policy perspective drug price ... In medicine, a term used to describe problems patient have related to the cost of healthcare is financial toxicity. The term is often associated with out ... read more

Looking for another news?


Cancer drugs get a new consumer's guide

The prostate cancer drug cabazitaxel (marketed as Jevtana) also was awarded only 16 points, despite a monthly price tag of $10,700 ... forged in an era before "precision medicine" promised to tailor t... read more


HTG Molecular: Entering Stage Of Growth And Momentum

According to their website, HTG Molecular Diagnostics (HTGM), Inc.'s mission is to empower precision medicine at the local ... took action to advance innovative personalized medicine for Medicare pati... read more

ASCO 2018: Advancing From Precision Medicine to Precision Care

The theme of this year’s ASCO was an important one: Delivering Discoveries: Expanding the Reach of Precision Medicine ... on the growing financial burden of cancer on the patient — what we now refer t... read more

Physician entrepreneur seeks to redefine physician and patient engagement

It negatively impacts physician health and patient care. Healthcare organizations may suffer significant financial losses due to physician ... and digital health to help improve cancer care and precis... read more

The possibility—and pitfalls—of precision medicine

Precision medicine is lauded by some medical professionals and hopeful patients for ... environment—the toxic environment we live in—our behavior, as well as social and economic factors.” Focusing on ... read more

COUNTERPOINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer

At 1 and 2 years, there was no difference in toxicity. This analysis included patients with high-risk locally advanced disease.[8] Despite these recent advances, for most patients, metastatic prostate ... read more

Cancer Genetics' (CGIX) Management on Q4 2017 Results - Earnings Call Transcript

The goal of this process which included analysis of our financial and laboratory operations, pipeline programs, revenue streams and financial resources was to devise a transformative plan for Cancer G... read more

Allscripts CEO lays out genomics strategy to users

Soon-Shiong argued that advances in genomics and molecular medicine make possible precision ... patients' genomes and tailoring individualized drug regimens that insurers will cover, oncologists can b... read more

Perspectives: The Hidden Cause Of Death — High Drug Prices

Mehtani, 6/4) The Hill: Cutting Costs Could Be The Key To Curing Cancer The first question often asked when learning ... the treatment for the patient using tumor-based biomarkers. This approach is ca... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us